Stem cells show early promise in ALS

In a mouse study of amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease), injected neural stem cells moved to the spinal cord and multiplied, extending life span 20 days and improving muscle function 15%. In the study, which will be  presented at the American Academy of Neurology's 65th Annual Meeting in March, the neural stem cells were created from human induced pluripotent stem cells (iPSCs). Press release

Suggested Articles

Antibiotics dubbed odilorhabdins (ODLs), inspired by soil-dwelling nematodes, hold promise for treating antibiotic-resistant infections.

A PureTech startup is developing an immune-responsive hydrogel that releases a corticosteroid into arthritic joints based on their level of inflammation.

A trial of a retinal implant built from embryonic stem cells produced encouraging results in patients with dry age-related macular degeneration.